Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Balkan Medical Journal|April 19, 2017
Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation SettingAli Hakan Kaya, Emre Tekgündüz, Fazilet Duygu, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 22, 2021
Does myeloma genetic have an effect on stem cell mobilization?Semih Başcı, Tuğçe Nur Yiğenoğlu, Samet Yaman, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 27, 2016
First hematopoietic cell transplantation in Uzbekistan: Progress through education and cooperationKhamid Karimov, Emre Tekgündüz, Alonur Saidov, et al.Leukemia Research|February 20, 2022
Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?Bahar Uncu Ulu, Semih Başcı, Mehmet Bakırtaş, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 22, 2012
Plerixafor use in patients with previous mobilization failure: A multicenter experienceEmre Tekgündüz, Fevzi Altuntaş, Serdar Sıvgın, et al.Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 28, 2019
Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter StudyRafiye Çiftçiler, Ömür Gökmen Sevindik, Ali İrfan Emre Tekgündüz, et al.Emerging Infectious Diseases|July 26, 2014
Dengue virus transmission by blood stem cell donor after travel to Sri Lanka; Germany, 2013Michael Punzel, Gülay Korukluoğlu, Dilek Yagci Caglayik, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 27, 2020
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experienceHikmettullah Batgi, Alparslan Merdin, Mehmet Sinan Dal, et al.Hematology, Transfusion and Cell Therapy|February 15, 2025
Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilizationMehmet Bakırtaş, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, et al.Journal of Chemotherapy (Florence, Italy)|November 4, 2017
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapyAli Hakan Kaya, Emre Tekgündüz, Kadir Ilkkiliç, et al.Pageof 9